Vesper Bio
Pre-clinicalVesper Bio | Targeting Sortilin. Transforming Minds. Developing Oral Therapy for Frontotemporal Degeneration.
Founded
2020
Focus
Small Molecules
About
Vesper Bio | Targeting Sortilin. Transforming Minds. Developing Oral Therapy for Frontotemporal Degeneration.
Funding History
2Total raised: $36.5M
Series A$28MNovo HoldingsNov 15, 2023
Seed$8.5MNovo HoldingsJun 15, 2022
Company Info
TypePrivate
Founded2020
LocationCopenhagen, Denmark
StagePre-clinical
Contact
SIMILAR COMPANIES
MipSalus
Pre-clinical · Copenhagen
FluoGuide
Pre-clinical · Copenhagen
Fuse Vectors
Pre-clinical · Copenhagen
Fida Biosystems
Pre-clinical · Copenhagen
CerCell
Pre-clinical · Copenhagen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile